Nesen, A., K. Savicheva, P. Semenovykh, and V. Galchiskaya. “Vasopressin Marker Copeptin and the Development of Renal and Metabolic Disorders in Patients With Type 2 Diabetes”. Ukrainian Journal of Nephrology and Dialysis, no. 3(75), June 2022, pp. 55-62, doi:10.31450/ukrjnd.3(75).2022.07.